NewsAAAAI: Omalizumab as Effective as Multifood Oral Immunotherapy for Individuals With Food AllergyHealthDay.comMarch 6, 2026
NewsAAOS: GLP-1 Receptor Agonist Use Increases Five-Year Risk for OsteoporosisHealthDay.comMarch 6, 2026
NewsSubset of Patients With Follicular Lymphoma Can Achieve Cure With CHOP-Based ChemoimmunotherapyHealthDay.comMarch 6, 2026
NewsGuidance Lists New First-Line Treatment for Severe Malaria in the U.S.HealthDay.comMarch 28, 2019
